216 related articles for article (PubMed ID: 19100850)
21. Enhancement of contextual fear-conditioning by putative (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor modulators and N-methyl-D-aspartate (NMDA) receptor antagonists in DBA/2J mice.
Lu Y; Wehner JM
Brain Res; 1997 Sep; 768(1-2):197-207. PubMed ID: 9369316
[TBL] [Abstract][Full Text] [Related]
22. The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications.
Zaveri NT
Curr Top Med Chem; 2011; 11(9):1151-6. PubMed ID: 21050175
[TBL] [Abstract][Full Text] [Related]
23. Accumbal opioid receptors modulate cue competition in one-trial overshadowing.
Iordanova MD; Haralambous T; McNally GP; Westbrook RF
Brain Res; 2013 Jun; 1517():57-67. PubMed ID: 23603410
[TBL] [Abstract][Full Text] [Related]
24. Coantagonism of glutamate receptors and nicotinic acetylcholinergic receptors disrupts fear conditioning and latent inhibition of fear conditioning.
Gould TJ; Lewis MC
Learn Mem; 2005; 12(4):389-98. PubMed ID: 16077017
[TBL] [Abstract][Full Text] [Related]
25. A combined pharmacological and genetic approach to investigate the role of orphanin FQ in learning and memory.
Higgins GA; Kew JN; Richards JG; Takeshima H; Jenck F; Adam G; Wichmann J; Kemp JA; Grottick AJ
Eur J Neurosci; 2002 Mar; 15(5):911-22. PubMed ID: 11906533
[TBL] [Abstract][Full Text] [Related]
26. Factors governing single-trial contextual fear conditioning in the weanling rat.
Burman MA; Murawski NJ; Schiffino FL; Rosen JB; Stanton ME
Behav Neurosci; 2009 Oct; 123(5):1148-52. PubMed ID: 19824781
[TBL] [Abstract][Full Text] [Related]
27. Mu-opioid peptide (MOP) and nociceptin/orphanin FQ peptide (NOP) receptor activation both contribute to the discriminative stimulus properties of cebranopadol in the rat.
Tzschentke TM; Rutten K
Neuropharmacology; 2018 Feb; 129():100-108. PubMed ID: 29155273
[TBL] [Abstract][Full Text] [Related]
28. Acute exposure to saccharin reduces morphine analgesia in the the rat: evidence for involvement of N-methyl-D-aspartate and peripheral opioid receptors.
McNally GP; Westbrook RF
Psychopharmacology (Berl); 2000 Mar; 149(1):56-62. PubMed ID: 10789883
[TBL] [Abstract][Full Text] [Related]
29. Latent inhibition of cued fear conditioning: an NMDA receptor-dependent process that can be established in the presence of anisomycin.
Lewis MC; Gould TJ
Eur J Neurosci; 2004 Aug; 20(3):818-26. PubMed ID: 15255992
[TBL] [Abstract][Full Text] [Related]
30. Reconsolidation and extinction of conditioned fear: inhibition and potentiation.
Lee JL; Milton AL; Everitt BJ
J Neurosci; 2006 Sep; 26(39):10051-6. PubMed ID: 17005868
[TBL] [Abstract][Full Text] [Related]
31. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
32. NMDA receptors and the ontogeny of post-shock and retention freezing during contextual fear conditioning.
Miller LA; Heroux NA; Stanton ME
Dev Psychobiol; 2020 Apr; 62(3):380-385. PubMed ID: 31621064
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterization of the nociceptin/orphanin FQ receptor on ethanol-mediated motivational effects in infant and adolescent rats.
Miranda-Morales RS; Pautassi RM
Behav Brain Res; 2016 Feb; 298(Pt A):88-96. PubMed ID: 25907741
[TBL] [Abstract][Full Text] [Related]
34. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
[TBL] [Abstract][Full Text] [Related]
35. The effect of hippocampal NMDA receptor blockade by MK-801 on cued fear extinction.
Zhang B; Li CY; Wang XS
Behav Brain Res; 2017 Aug; 332():200-203. PubMed ID: 28578988
[TBL] [Abstract][Full Text] [Related]
36. Functional interaction of mGlu5 and NMDA receptors in aversive learning in rats.
Fowler SW; Ramsey AK; Walker JM; Serfozo P; Olive MF; Schachtman TR; Simonyi A
Neurobiol Learn Mem; 2011 Jan; 95(1):73-9. PubMed ID: 21093598
[TBL] [Abstract][Full Text] [Related]
37. A Novel and Selective Nociceptin Receptor (NOP) Agonist (1-(1-((cis)-4-isopropylcyclohexyl)piperidin-4-yl)-1H-indol-2-yl)methanol (AT-312) Decreases Acquisition of Ethanol-Induced Conditioned Place Preference in Mice.
Zaveri NT; Marquez PV; Meyer ME; Polgar WE; Hamid A; Lutfy K
Alcohol Clin Exp Res; 2018 Feb; 42(2):461-471. PubMed ID: 29215139
[TBL] [Abstract][Full Text] [Related]
38. Ontogeny and neural substrates of the context preexposure facilitation effect.
Schiffino FL; Murawski NJ; Rosen JB; Stanton ME
Neurobiol Learn Mem; 2011 Feb; 95(2):190-8. PubMed ID: 21129493
[TBL] [Abstract][Full Text] [Related]
39. The role of group I metabotropic glutamate receptors in acquisition and expression of contextual and auditory fear conditioning in rats - a comparison.
Gravius A; Barberi C; Schäfer D; Schmidt WJ; Danysz W
Neuropharmacology; 2006 Dec; 51(7-8):1146-55. PubMed ID: 16905160
[TBL] [Abstract][Full Text] [Related]
40. Nociceptin and the NOP receptor in aversive learning in mice.
Adem A; Madjid N; Kahl U; Holst S; Sadek B; Sandin J; Terenius L; Ögren SO
Eur Neuropsychopharmacol; 2017 Dec; 27(12):1298-1307. PubMed ID: 29102248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
